165 related articles for article (PubMed ID: 25031742)
1. High expression of GPER1, EGFR and CXCR1 is associated with lymph node metastasis in papillary thyroid carcinoma.
Tang C; Yang L; Wang N; Li L; Xu M; Chen GG; Liu ZM
Int J Clin Exp Pathol; 2014; 7(6):3213-23. PubMed ID: 25031742
[TBL] [Abstract][Full Text] [Related]
2. Role of GPER1, EGFR and CXCR1 in differentiating between malignant follicular thyroid carcinoma and benign follicular thyroid adenoma.
Zhao L; Zhu XY; Jiang R; Xu M; Wang N; Chen GG; Liu ZM
Int J Clin Exp Pathol; 2015; 8(9):11236-47. PubMed ID: 26617848
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of HIF-1α, metallothionein and SLUG is associated with high TNM stage and lymph node metastasis in papillary thyroid carcinoma.
Wang N; Dong CR; Jiang R; Tang C; Yang L; Jiang QF; Chen GG; Liu ZM
Int J Clin Exp Pathol; 2014; 7(1):322-30. PubMed ID: 24427353
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of HIF-2α, TWIST, and CXCR4 is associated with lymph node metastasis in papillary thyroid carcinoma.
Wang N; Luo HJ; Yin GB; Dong CR; Xu M; Chen GG; Liu ZM
Clin Dev Immunol; 2013; 2013():589423. PubMed ID: 24288553
[TBL] [Abstract][Full Text] [Related]
5. Expression of TGF-β1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma.
Wang N; Jiang R; Yang JY; Tang C; Yang L; Xu M; Jiang QF; Liu ZM
J Mol Histol; 2014 Aug; 45(4):391-9. PubMed ID: 24276590
[TBL] [Abstract][Full Text] [Related]
6. Concomitant high expression of ERα36, EGFR and HER2 is associated with aggressive behaviors of papillary thyroid carcinomas.
Dai YJ; Qiu YB; Jiang R; Xu M; Zhao L; Chen GG; Liu ZM
Sci Rep; 2017 Sep; 7(1):12279. PubMed ID: 28947799
[TBL] [Abstract][Full Text] [Related]
7. The gene expression of GPER1 is low in fresh samples of papillary thyroid carcinoma (PTC), and in silico analysis.
Bertoni APS; Manfroi PA; Tomedi J; Assis-Brasil BM; de Souza Meyer EL; Furlanetto TW
Mol Cell Endocrinol; 2021 Sep; 535():111397. PubMed ID: 34273443
[TBL] [Abstract][Full Text] [Related]
8. Decreased Expression of Estrogen Receptors Is Associated with Tumorigenesis in Papillary Thyroid Carcinoma.
Chou CK; Chi SY; Hung YY; Yang YC; Fu HC; Wang JH; Chen CC; Kang HY
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162942
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of cytokeratin 17 is associated with the development of papillary thyroid carcinoma and the presence of lymph node metastasis.
Kim HS; Lee JJ; Do SI; Kim K; Do IG; Kim DH; Chae SW; Sohn JH
Int J Clin Exp Pathol; 2015; 8(5):5695-701. PubMed ID: 26191283
[TBL] [Abstract][Full Text] [Related]
10. High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.
Išić Denčić T; Bartolome A; Šelemetjev S; Đorić I; Tatić S; Živaljević V; Cvejić D
Exp Mol Pathol; 2018 Oct; 105(2):181-189. PubMed ID: 30077672
[TBL] [Abstract][Full Text] [Related]
11. EGFR and CXCR1 expression in thyroid carcinoma in Qassim Region-Saudi Arabia: Correlation with clinicopathological parameters.
Omran OM
Pathophysiology; 2019 Jun; 26(2):145-151. PubMed ID: 31031057
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of epidermal growth factor receptor and its downstream effector, focal adhesion kinase, correlates with papillary thyroid carcinoma progression.
Šelemetjev S; Bartolome A; Išić Denčić T; Đorić I; Paunović I; Tatić S; Cvejić D
Int J Exp Pathol; 2018 Apr; 99(2):87-94. PubMed ID: 29665129
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma.
Fisher KE; Jani JC; Fisher SB; Foulks C; Hill CE; Weber CJ; Cohen C; Sharma J
J Surg Res; 2013 Nov; 185(1):217-24. PubMed ID: 23746767
[TBL] [Abstract][Full Text] [Related]
14. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.
Wu G; Zhou Y; Li T; Guo J; Zhou Z
J Int Med Res; 2013 Jun; 41(3):816-24. PubMed ID: 23685894
[TBL] [Abstract][Full Text] [Related]
16. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
17. Co-overexpression of p53 protein and epidermal growth factor receptor in human papillary thyroid carcinomas correlated with lymph node metastasis, tumor size and clinicopathologic stage.
Chen BK; Ohtsuki Y; Furihata M; Takeuchi T; Iwata J; Liang SB; Sonobe H
Int J Oncol; 1999 Nov; 15(5):893-8. PubMed ID: 10536170
[TBL] [Abstract][Full Text] [Related]
18. Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma.
Buitrago D; Keutgen XM; Crowley M; Filicori F; Aldailami H; Hoda R; Liu YF; Hoda RS; Scognamiglio T; Jin M; Fahey TJ; Zarnegar R
Ann Surg Oncol; 2012 Mar; 19(3):973-80. PubMed ID: 21879273
[TBL] [Abstract][Full Text] [Related]
19. 17β-estradiol promotes the invasion and migration of nuclear estrogen receptor-negative breast cancer cells through cross-talk between GPER1 and CXCR1.
Jiang QF; Wu TT; Yang JY; Dong CR; Wang N; Liu XH; Liu ZM
J Steroid Biochem Mol Biol; 2013 Nov; 138():314-24. PubMed ID: 23907016
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer.
Dong W; Li J; Zhang H; Huang Y; He L; Wang Z; Shan Z; Teng W
Int J Clin Exp Pathol; 2015; 8(6):7149-56. PubMed ID: 26261608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]